Starting Primary Prevention Earlier With Statins-Reference-Cited by-同舟云学术

Starting Primary Prevention Earlier With Statins

Published:2014-11 Issue:9 Volume:114 Page:1437-1442
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Robinson Jennifer G.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference41 articles.

1. Heart disease and stroke statistics—2013 update: a report from the American Heart Association;Go;Circulation,2013

2. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Stone;J Am Coll Cardiol,2014

3. National Clinical Guideline Center. Lipid modification: cardiovascuar risk assessment and the modification of blood lpids for the primary and secondary prevention of cardiovascular disease. July 2014. NICE clinical guidance 181. guidance.nice.org/uk/og181. Accessed August 29, 2014.

4. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS;Downs;JAMA,1998

5. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA study): a prospective randomised controlled trial;Nakamura;Lancet,2006

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Marked plaque regression in homozygous familial hypercholesterolemia;Atherosclerosis;2021-06

2. Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working Group;Journal of the American Heart Association;2020-10-06

3. Exercise-Pharmacology Interactions: Metformin, Statins, and Healthspan;Physiology;2020-09-01

4. Projections of incident atherosclerotic cardiovascular disease and incident type 2 diabetes across evolving statin treatment guidelines and recommendations: A modelling study;PLOS Medicine;2020-08-26

5. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at “Extreme” ASCVD Risk;Current Diabetes Reports;2019-11-21